Georgia should position itself as a location for European bioscience firms locating operations abroad to avoid Europe’s stringent research regulations, said David Dodd, president of Norcross-based Serologicals Corp., at a…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Phil Bolton is the founder and publisher emeritus of Global Atlanta.